SE0203304D0 - Novel Coumpounds - Google Patents
Novel CoumpoundsInfo
- Publication number
- SE0203304D0 SE0203304D0 SE0203304A SE0203304A SE0203304D0 SE 0203304 D0 SE0203304 D0 SE 0203304D0 SE 0203304 A SE0203304 A SE 0203304A SE 0203304 A SE0203304 A SE 0203304A SE 0203304 D0 SE0203304 D0 SE 0203304D0
- Authority
- SE
- Sweden
- Prior art keywords
- coumpounds
- novel
- compounds
- racemates
- prophylaxis
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 206010065390 Inflammatory pain Diseases 0.000 abstract 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0203304A SE0203304D0 (sv) | 2002-11-07 | 2002-11-07 | Novel Coumpounds |
| DE60306546T DE60306546T2 (de) | 2002-11-07 | 2003-11-06 | Entzündungshemmende 3-arylthio-3-thiazolylalkylamine |
| AU2003278667A AU2003278667A1 (en) | 2002-11-07 | 2003-11-06 | Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| EP03770201A EP1562920B1 (en) | 2002-11-07 | 2003-11-06 | Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| PCT/SE2003/001712 WO2004041794A1 (en) | 2002-11-07 | 2003-11-06 | Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| AT03770201T ATE331711T1 (de) | 2002-11-07 | 2003-11-06 | Entzündungshemmende 3-arylthio-3- thiazolylalkylamine |
| US10/534,191 US20060040992A1 (en) | 2002-11-07 | 2003-11-06 | Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| JP2004549780A JP2006506414A (ja) | 2002-11-07 | 2003-11-06 | 抗炎症性３−アリールチオ−３−チアゾリル−アルキルアミン |
| ES03770201T ES2268441T3 (es) | 2002-11-07 | 2003-11-06 | 3-ariltio-3-tiazolil-alquilaminas antiinflamatorias. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0203304A SE0203304D0 (sv) | 2002-11-07 | 2002-11-07 | Novel Coumpounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0203304D0 true SE0203304D0 (sv) | 2002-11-07 |
Family
ID=20289508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0203304A SE0203304D0 (sv) | 2002-11-07 | 2002-11-07 | Novel Coumpounds |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060040992A1 (sv) |
| EP (1) | EP1562920B1 (sv) |
| JP (1) | JP2006506414A (sv) |
| AT (1) | ATE331711T1 (sv) |
| AU (1) | AU2003278667A1 (sv) |
| DE (1) | DE60306546T2 (sv) |
| ES (1) | ES2268441T3 (sv) |
| SE (1) | SE0203304D0 (sv) |
| WO (1) | WO2004041794A1 (sv) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR035700A1 (es) * | 2001-05-08 | 2004-06-23 | Astrazeneca Ab | Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados |
| SI2215092T1 (sl) | 2007-10-19 | 2012-04-30 | Boehringer Ingelheim Int | Substituirani piperidino-dihidrotienopirimidini |
| PL2379525T3 (pl) | 2008-12-19 | 2016-01-29 | Centrexion Therapeutics Corp | Cykliczne pirymidyno-4-karboksamidy jako antagoniści receptora CCR2 do leczenia stanów zapalnych, astmy oraz COPD |
| JP5658272B2 (ja) | 2009-12-17 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｃｒ２の新規アンタゴニスト及びこれらの使用 |
| RS53555B1 (en) | 2009-12-17 | 2015-02-27 | Boehringer Ingelheim International Gmbh | NEW CCR2 RECEPTOR ANTAGONISTS AND THEIR APPLICATIONS |
| CA2786245A1 (en) | 2010-01-29 | 2011-08-04 | Boehringer Ingelheim International Gmbh | Substituted naphthyridines and their use as syk kinase inhibitors |
| EP2569295B1 (en) | 2010-05-12 | 2014-11-19 | Boehringer Ingelheim International GmbH | New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| JP2013526507A (ja) | 2010-05-12 | 2013-06-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用 |
| US8841313B2 (en) | 2010-05-17 | 2014-09-23 | Boehringer Ingelheim International Gmbh | CCR2 antagonists and uses thereof |
| EP2576542B1 (en) | 2010-05-25 | 2015-04-22 | Boehringer Ingelheim International GmbH | Cyclic amide derivatives of pyridazine-3-carboxylic acids and their use in the treatment of pulmonary, pain, immune related and cardiovascular diseases |
| WO2011151251A1 (en) | 2010-06-01 | 2011-12-08 | Boehringer Ingelheim International Gmbh | New ccr2 antagonists |
| WO2012101013A1 (en) | 2011-01-28 | 2012-08-02 | Boehringer Ingelheim International Gmbh | Substituted pyridinyl-pyrimidines and their use as medicaments |
| EP2721025B1 (en) | 2011-06-16 | 2015-11-25 | Boehringer Ingelheim International Gmbh | New selective ccr2 antagonists |
| JP5786258B2 (ja) | 2011-07-15 | 2015-09-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規かつ選択的なｃｃｒ２拮抗薬 |
| EP2736886B1 (en) | 2011-07-26 | 2016-09-14 | Boehringer Ingelheim International GmbH | Substituted quinolines and their use as medicaments |
| US20130059866A1 (en) | 2011-08-24 | 2013-03-07 | Boehringer Ingelheim International Gmbh | Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| US9096579B2 (en) | 2012-04-20 | 2015-08-04 | Boehringer Ingelheim International Gmbh | Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments |
| JP6535022B2 (ja) | 2014-03-19 | 2019-06-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ヘテロアリールｓｙｋ阻害剤 |
| GB201512635D0 (en) | 2015-07-17 | 2015-08-26 | Ucl Business Plc | Uses of therapeutic compounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2688638A (en) * | 1951-07-17 | 1954-09-07 | Givaudan Corp | Nu-(beta-phenoxyethyl) haloethylamines |
| US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
| FR2432500A1 (fr) * | 1978-02-24 | 1980-02-29 | Roussel Uclaf | Nouveaux derives de la benzene propanamine et leurs sels, procede de preparation et application a titre de medicaments |
| US4325953A (en) * | 1979-09-14 | 1982-04-20 | John Wyeth And Brother Limited | 4-Aryl-4-aryloxypiperidines |
| DE3138550A1 (de) * | 1981-09-28 | 1983-04-07 | Boehringer Ingelheim KG, 6507 Ingelheim | Substituierte 2-phenyl-2-(pyridyloxy)-ethylamine und isostere verbindungen, verfahren zu ihrer herstellung und verwendung |
| DE3328348A1 (de) * | 1983-08-05 | 1985-02-14 | Degussa Ag, 6000 Frankfurt | Verfahren zur duennschichtchromatographischen trennung von enantiomeren |
| US4902710A (en) * | 1988-12-14 | 1990-02-20 | Eli Lilly And Company | Serotonin and norepinephrine uptake inhibitors |
| GB0004152D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
| GB0004149D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
| GB0004153D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
| GB0004151D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
| AR035700A1 (es) * | 2001-05-08 | 2004-06-23 | Astrazeneca Ab | Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados |
| SE0102640D0 (sv) * | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
| SE0102641D0 (sv) * | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
| AU2002366210A1 (en) * | 2001-11-21 | 2003-06-10 | Danmarks Farmaceutiske Hojskole | Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
-
2002
- 2002-11-07 SE SE0203304A patent/SE0203304D0/sv unknown
-
2003
- 2003-11-06 AU AU2003278667A patent/AU2003278667A1/en not_active Abandoned
- 2003-11-06 AT AT03770201T patent/ATE331711T1/de not_active IP Right Cessation
- 2003-11-06 WO PCT/SE2003/001712 patent/WO2004041794A1/en active IP Right Grant
- 2003-11-06 JP JP2004549780A patent/JP2006506414A/ja not_active Withdrawn
- 2003-11-06 ES ES03770201T patent/ES2268441T3/es not_active Expired - Lifetime
- 2003-11-06 EP EP03770201A patent/EP1562920B1/en not_active Expired - Lifetime
- 2003-11-06 US US10/534,191 patent/US20060040992A1/en not_active Abandoned
- 2003-11-06 DE DE60306546T patent/DE60306546T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1562920B1 (en) | 2006-06-28 |
| WO2004041794A1 (en) | 2004-05-21 |
| DE60306546D1 (de) | 2006-08-10 |
| ES2268441T3 (es) | 2007-03-16 |
| US20060040992A1 (en) | 2006-02-23 |
| ATE331711T1 (de) | 2006-07-15 |
| AU2003278667A1 (en) | 2004-06-07 |
| DE60306546T2 (de) | 2007-07-05 |
| WO2004041794A8 (en) | 2005-03-10 |
| JP2006506414A (ja) | 2006-02-23 |
| EP1562920A1 (en) | 2005-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03010142A (es) | Nuevos derivados de arilheteroalquilamina. | |
| SE0203304D0 (sv) | Novel Coumpounds | |
| SE0302487D0 (sv) | Novel compounds | |
| UA84175C2 (ru) | Гетероциклические ингибиторы мэк и их применение | |
| SE0202463D0 (sv) | Novel compounds | |
| TW200700392A (en) | Novel compounds | |
| MY137133A (en) | Novel compounds | |
| TW200626601A (en) | Novel compounds | |
| SE0302486D0 (sv) | Novel compounds | |
| SE0302324D0 (sv) | Novel compounds | |
| SE0302323D0 (sv) | Novel compounds | |
| BRPI0412999A (pt) | 2-aminotetralina substituìda para tratamento de depressão | |
| SE9803518D0 (sv) | Novel compounds | |
| SE0302756D0 (sv) | Novel Compounds | |
| SE9803773D0 (sv) | Compounds | |
| SE0102641D0 (sv) | Novel compounds | |
| SE0202461D0 (sv) | Novel compounds | |
| DE60103034D1 (de) | Neue phenylheteroalkylamin-derivate | |
| SE0102640D0 (sv) | Novel compounds | |
| SE0102639D0 (sv) | Novel compounds | |
| SE0300907D0 (sv) | Novel compounds | |
| SE0202280D0 (sv) | Novel compounds | |
| SE0103325D0 (sv) | Novel compounds | |
| SE9904676D0 (sv) | Novel compounds | |
| SE9901901D0 (sv) | Compounds |